Investing.com India12m
Morgan Stanley upgrades Zealand Pharma to Buy on ’long-term obesity potential’
Investing.com -- Morgan Stanley (NYSE: MS) upgraded its rating on Zealand Pharma (NASDAQ: ZEAL) shares to Overweight from ...
STAT11h
Zealand’s obesity strategy and Immunovant’s curious development plan
For more on Immunovant’s new data, go here; for more on Sarepta’s gene therapy, go here; to learn more about Zealand’s deal with Roche, go here; and to read about the panels at our Breakthrough East ...
Australia’s PBS means consumers pay less for expensive medicines. Here’s how this system works
The United States pharmaceutical lobby has complained to US President Donald Trump that Australia’s Pharmaceutical Benefits ...
Mirage News20h
Australias PBS Cuts Costs for Pricey Meds: Heres How
The United States pharmaceutical lobby has complained to US President Donald Trump that Australia's Pharmaceutical Benefits ...
Indiatimes11h
Natco Pharma Share Price
Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 14,337.75 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...